Flow Cytometric Analysis of Endothelial Progenitor Cells

May 27, 2015

Endothelial Progenitor Cells (EPCs), first described by Asahara et al. in 1997, have become an important tool in the field of cardiovascular research (1). It is believed that they serve an important role in mitigating dysfunction by maintaining vascular homeostasis through repair and/or growth of blood vessels (1, 3, 4). The difficulty with studying EPCs has been in the lack of a clearly defined antigenic profile. Most of the markers used to isolate and study EPCs, such as the VEGF receptor-2 and CD34, have come from deductions and assumptions based on profiles of related cells, such as Hematopoietic Stem Cells (HSCs) and endothelial cells

Spotlight

Health Resources International Ltd

Health Resources International Limited was established in 2003 in the United Kingdom. The company was originally set up to supply UK organizations (both public and private) with hospital consultants and specialists from Eastern Europe. We have dealt with consultants, junior doctors and general practitioners (primary care physicians), supplying them on a fixed, short term, sessional, rotational or locum basis. Since incorporation we have recruited a couple of hundreds of medical professionals in the UK, the majority of which have been consultants in permanent positions.

OTHER WHITEPAPERS
news image

Accelerating the Healthcare Mainframe to the Speed of DevOps

whitePaper | September 23, 2022

Many of the largest healthcare organizations rely on the mainframe to run their businesses and safeguard a wealth of sensitive data, from patient records to billing information, but why is the mainframe the platform of choice for so many?

Read More
news image

Medical Implants Product Guide

whitePaper | April 7, 2022

For more than 30 years, the NuSil™ brand has been continuously supplying medical device manufacturers with silicones of the highest purity and long-term stability for medical implant applications.

Read More
news image

The Promise of Robotic Process Automation and Artificial Intelligence in Revenue Cycle Management

whitePaper | August 25, 2022

The revenue cycle process has a long and cumbersome history that continues to become more complex as policies, payer relationships, and patient expectations evolve.

Read More
news image

The value of diverse patient representation and engagementin cancer treatment

whitePaper | June 21, 2022

To improve outcomes for cancer patients and take advantage of the groundbreaking scientific and technological progress made in oncology prevention, diagnosis, therapy, and care over recent years, it is of crucial importance to ensure all patients with cancer have a role and an ongoing dialogue with the healthcare team.

Read More
news image

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern. Until recently, researchers were limited by the lack of a specific ICD-10 diagnosis code for post-COVID conditions.

Read More
news image

Test Resource

whitePaper | May 18, 2021

Test Resource The criteria of patient satisfaction have changed dramatically. The priority of your healthcare business is to provide patients the right treatment. But nowadays, you cannot excel in your service

Read More

Spotlight

Health Resources International Ltd

Health Resources International Limited was established in 2003 in the United Kingdom. The company was originally set up to supply UK organizations (both public and private) with hospital consultants and specialists from Eastern Europe. We have dealt with consultants, junior doctors and general practitioners (primary care physicians), supplying them on a fixed, short term, sessional, rotational or locum basis. Since incorporation we have recruited a couple of hundreds of medical professionals in the UK, the majority of which have been consultants in permanent positions.

Events